BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34981488)

  • 1. Nanomicellar Curcumin Supplementation Improves the Clinical Manifestations of HAM/TSP Patients.
    Mohammadi A; Yazdi SZ; Poursina Z; Hampson IN; Vakili V; Sahebkar A; Akbarien MM; Rahimi H; Vakili R; Boostani R; Rafatpanah H
    Adv Exp Med Biol; 2021; 1328():347-359. PubMed ID: 34981488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triple Therapy with Prednisolone, Pegylated Interferon and Sodium Valproate Improves Clinical Outcome and Reduces Human T-Cell Leukemia Virus Type 1 (HTLV-1) Proviral Load, Tax and HBZ mRNA Expression in Patients with HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis.
    Boostani R; Vakili R; Hosseiny SS; Shoeibi A; Fazeli B; Etemadi MM; Sabet F; Valizade N; Rezaee SA
    Neurotherapeutics; 2015 Oct; 12(4):887-95. PubMed ID: 26174324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of HTLV-1 virulence factors (HBZ, Tax, proviral load), HLA class I and plasma neopterin on manifestation of HTLV-1 associated myelopathy tropical spastic paraparesis.
    Tarokhian H; Taghadosi M; Rafatpanah H; Rajaei T; Azarpazhooh MR; Valizadeh N; Rezaee SAR
    Virus Res; 2017 Jan; 228():1-6. PubMed ID: 27845163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Saito M; Matsuzaki T; Satou Y; Yasunaga J; Saito K; Arimura K; Matsuoka M; Ohara Y
    Retrovirology; 2009 Feb; 6():19. PubMed ID: 19228429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon Lambda Family along with HTLV-1 Proviral Load, Tax, and HBZ Implicated in the Pathogenesis of Myelopathy/Tropical Spastic Paraparesis.
    Mozhgani SH; Jahantigh HR; Rafatpanah H; Valizadeh N; Mohammadi A; Basharkhah S; Rezaee SA
    Neurodegener Dis; 2018; 18(2-3):150-155. PubMed ID: 29990995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HTLV-1 proviral integration sites differ between asymptomatic carriers and patients with HAM/TSP.
    Niederer HA; Laydon DJ; Melamed A; Elemans M; Asquith B; Matsuoka M; Bangham CR
    Virol J; 2014 Sep; 11():172. PubMed ID: 25270762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coevolution of HTLV-1-HBZ, Tax, and proviral load with host IRF-1 and CCNA-2 in HAM/TSP patients.
    Saffari M; Rahimzada M; Mirhosseini A; Ghezaldasht SA; Valizadeh N; Moshfegh M; Moradi MT; Rezaee SA
    Infect Genet Evol; 2022 Sep; 103():105337. PubMed ID: 35835355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of HTLV-1 HBZ and proviral load, together with host IFN λ3, in pathogenesis of HAM/TSP.
    Mozhgani SH; Jaberi N; Rezaee SA; Bustani R; Jazayeri SM; Akbarin MM; Milani S; Tarokhian H; Norouzi M
    J Med Virol; 2017 Jun; 89(6):1102-1107. PubMed ID: 27787900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The IL-18, IL-12, and IFN-γ expression in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients, HTLV-1 carriers, and healthy subjects.
    Bidkhori HR; Hedayati-Moghaddam MR; Mosavat A; Valizadeh N; Tadayon M; Ahmadi Ghezeldasht S; Rafatpanah H; Rezaee SA
    J Neurovirol; 2020 Jun; 26(3):338-346. PubMed ID: 32270468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).
    Baratella M; Forlani G; Raval GU; Tedeschi A; Gout O; Gessain A; Tosi G; Accolla RS
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005285. PubMed ID: 28095504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid receptors as new targets for HTLV-1 associated myelopathy (HAM/TSP) treatment.
    Fadaee A; Mohammadi FS; Ariaee N; Ahmadi Ghezeldasht S; Valizadeh N; Kheradmand F; Boostani R; Rafatpanah H; Rezaee SA
    Mult Scler Relat Disord; 2024 Jul; 87():105659. PubMed ID: 38704874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individuals.
    Enose-Akahata Y; Abrams A; Massoud R; Bialuk I; Johnson KR; Green PL; Maloney EM; Jacobson S
    Retrovirology; 2013 Feb; 10():19. PubMed ID: 23405908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strong correlation between tax and HBZ mRNA expression in HAM/TSP patients: distinct markers for the neurologic disease.
    Andrade RG; Gonçalves Pde C; Ribeiro MA; Romanelli LC; Ribas JG; Torres EB; Carneiro-Proietti AB; Barbosa-Stancioli EF; Martins ML
    J Clin Virol; 2013 Feb; 56(2):135-40. PubMed ID: 23127563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term safety and efficacy of mogamulizumab (anti-CCR4) for treating virus-associated myelopathy.
    Sato T; Yamauchi J; Yagishita N; Araya N; Takao N; Ohta Y; Inoue E; Takahashi M; Yamagishi M; Suzuki Y; Uchimaru K; Matsumoto N; Hasegawa Y; Yamano Y
    Brain; 2023 Aug; 146(8):3181-3191. PubMed ID: 37093965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of HTLV-1 Tax and HBZ in the Pathogenesis of HAM/TSP.
    Enose-Akahata Y; Vellucci A; Jacobson S
    Front Microbiol; 2017; 8():2563. PubMed ID: 29312243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
    Gessain A; Mahieux R
    Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EOS, an Ikaros family zinc finger transcription factor, interacts with the HTLV-1 oncoprotein Tax and is downregulated in peripheral blood mononuclear cells of HTLV-1-infected individuals, irrespective of clinical statuses.
    Naito T; Ushirogawa H; Fukushima T; Tanaka Y; Saito M
    Virol J; 2019 Dec; 16(1):160. PubMed ID: 31856855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Tax antibody levels in asymptomatic carriers, oligosymptomatic carriers, patients with rheumatologic disease or with HAM/TSP do not correlate with HTLV-1 proviral load.
    de Souza JG; da Fonseca FG; Martins ML; Martins CP; de Carvalho LD; Coelho-dos-Reis JG; Carneiro-Proietti AB; Martins-Filho OA; Barbosa-Stancioli EF;
    J Clin Virol; 2011 Jan; 50(1):13-8. PubMed ID: 20951636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of erectile dysfunction in individuals infected with human T-lymphotropic virus 1: a prospective cohort study.
    de Oliveira CJV; Neto JAC; Liberato de Matos SNF; Oliveira P; Tannus M; Castro N; Rocha PN; Carvalho EM
    J Sex Med; 2023 Feb; 20(3):269-276. PubMed ID: 36751985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of T Regulatory Lymphocytes Transcription Factors in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) Patients.
    Ghezeldasht SA; Sadeghian H; Azarpazhooh MR; Shamsian SAA; Rafatpanah H; Mahmoodi M; Rezaee SA
    Appl Biochem Biotechnol; 2017 Aug; 182(4):1403-1414. PubMed ID: 28101786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.